Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study (Q58204667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

title

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Norihiro Nishimoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Koichi Amano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Yasuhiko Hirabayashi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Takahiko Horiuchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Tomonori Ishii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Mitsuhiro Iwahashi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Masahiro Iwamoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Hitoshi Kohsaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Masakazu Kondo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Tsukasa Matsubara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Toshihide Mimura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Hisaaki Miyahara

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Shuji Ohta

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Yukihiko Saeki

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Kazuyoshi Saito

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Hajime Sano

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Kiyoshi Takasugi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Shigeto Tohma

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Tomomi Tsuru

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Yukitaka Ueki

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Jiro Yamana

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Jun Hashimoto

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Takaji Matsutani

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Miho Murakami

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

Nobuhiro Takagi

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

17-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

New therapies for treatment of rheumatoid arthritis

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/14397595.2013.854079

10.3109/14397595.2013.854079

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24261754 AND SRC:MED&resulttype=core&format=json

1 March 2020

1 reference